Detalles de la búsqueda
1.
Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical Trial.
Cancer Control
; 29: 10732748221120462, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35980734
2.
Association between schizophrenia and prostate cancer risk: Results from a pool of cohort studies and Mendelian randomization analysis.
Compr Psychiatry
; 115: 152308, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303584
3.
Cause-specific mortality of low and selective intermediate-risk prostate cancer patients with active surveillance or watchful waiting.
Transl Androl Urol
; 10(1): 154-163, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33532305
4.
A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ≥7.
Oncol Lett
; 20(3): 2906-2918, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32782607
5.
A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients.
Transl Androl Urol
; 9(6): 2572-2586, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33457230
Resultados
1 -
5
de 5
1
Próxima >
>>